For information on the latest Parkinson’s research please visit the European Parkinson’s Disease Association website.
Horse tranquilliser trial is awarded $750,000 grant for Parkinson’s research
Author: Simge Eva DoganPublished: 26 July 2018
Prep: Cook: Serves:
Researchers at the University of Arizona College of Medicine, Tucson, US, will be trialling ketamine – a recreational drug previously used to medicate people with depression – as a treatment for Parkinson’s.
The research – led by Dr Scott Sherman – is being supported with a three-year grant of $750,000 from the Arizona Biomedical Research Commission.
The initial clinical trial will test the effect of ketamine for treating dyskinesia in 10 patients. In addition, the researchers will carry out a separate rodent study to examine how the drug affects the brain.
Dr Scott Sherman, a neurologist at the University of Arizona College of Medicine, said: “Ketamine has been long overlooked. Now it could prove very useful for Parkinson’s patients.”
For more information on this article click here.
Share this story
Podcast: Deciding to have DBS surgery
Two guests discuss deep brain stimulation for Parkinson’s diseaseREAD MORE
Is your Parkinson’s making you tired?
Register for this free, hour-long webinarREAD MORE
The man who walked 80km in one day for Parkinson’s
Clint Bauld walked for 24 hours in aid of Parkinson’sREAD MORE